MSD India to set up vaccine lab in IndiaIllustrative image – not actual.

MSD India, the Indian unit of US based pharmaceutical company Merck, plans to set up a laboratory for developing vaccines in India.

The company plans to invest $150 million (approx Rs 750 crore) in lab set to come up at Jamia Millia Islamia University campus in Delhi. The lab - MSD Wellcome Trust Hilleman Laboratories - is a JV between Merck & Co, Inc and the Wellcome Trust. The lab will focus on developing vaccines pertaining to various diseases prevalent in tropical countries.

← All latest storiesBack to top →